# Chicago Rivet & Machine Co: overview CVR · NYSE · CIK 19871 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cvr.md) · [Financials](/companies/cvr/financials.md) · [Filings](/companies/cvr/filings.md) · [Insiders](/companies/cvr/insiders.md) Latest reported revenue: [$7.2m](/filings/0000019871-26-000022.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000019871-26-000022). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [6,970](/filings/0000019871-25-000008.md) | [4,104 d](/filings/0000019871-26-000004.md) | [7,246](/filings/0000019871-26-000014.md) | [7,298](/filings/0000019871-26-000022.md) | [7,360](/filings/0000019871-25-000008.md) | [5,986 d](/filings/0000019871-26-000004.md) | [6,852](/filings/0000019871-26-000014.md) | [7,237](/filings/0000019871-26-000022.md) | | Gross margin | % | [10.0%](/filings/0000019871-25-000008.md) | [(43.7%) d](/filings/0000019871-26-000004.md) | [22.9%](/filings/0000019871-26-000014.md) | [13.4%](/filings/0000019871-26-000022.md) | [18.1%](/filings/0000019871-25-000008.md) | [2.7% d](/filings/0000019871-26-000004.md) | [14.0%](/filings/0000019871-26-000014.md) | [7.8%](/filings/0000019871-26-000022.md) | | Operating margin | % | [(11.8%)](/filings/0000019871-25-000008.md) | [(86.4%) d](/filings/0000019871-26-000004.md) | [5.7%](/filings/0000019871-26-000014.md) | [(5.7%)](/filings/0000019871-26-000022.md) | [0.9%](/filings/0000019871-25-000008.md) | [(15.3%) d](/filings/0000019871-26-000004.md) | [(5.6%)](/filings/0000019871-26-000014.md) | [(14.3%)](/filings/0000019871-26-000022.md) | | Net margin | % | [(20.8%)](/filings/0000019871-25-000008.md) | [(88.0%) d](/filings/0000019871-26-000004.md) | [5.5%](/filings/0000019871-26-000022.md) | [(5.4%)](/filings/0000019871-26-000022.md) | [0.9%](/filings/0000019871-25-000008.md) | [(19.3%) d](/filings/0000019871-26-000004.md) | [(5.3%)](/filings/0000019871-26-000022.md) | [(13.7%)](/filings/0000019871-26-000022.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $k | [(369) d](/filings/0000019871-25-000008.md) | [(118) d](/filings/0000019871-26-000004.md) | [(2,063)](/filings/0000019871-26-000014.md) | [(22.8) d](/filings/0000019871-26-000022.md) | [502 d](/filings/0000019871-25-000008.md) | [24.3 d](/filings/0000019871-26-000004.md) | [(742)](/filings/0000019871-26-000014.md) | [(1,204) d](/filings/0000019871-26-000022.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [34.0](/filings/0001193125-23-083675.md) | [33.6](/filings/0001193125-24-080560.md) | [31.5](/filings/0000950170-25-046656.md) | [27.0](/filings/0000019871-26-000004.md) | [27.9](/filings/0000019871-26-000004.md) | | Gross margin | % | [19.0%](/filings/0001193125-23-083675.md) | [11.3%](/filings/0001193125-24-080560.md) | [(1.9%)](/filings/0000950170-25-046656.md) | [3.9%](/filings/0000019871-26-000004.md) | [14.8%](/filings/0000019871-26-000004.md) | | Operating margin | % | [4.0%](/filings/0001193125-23-083675.md) | [10.6%](/filings/0001193125-24-080560.md) | [(18.5%)](/filings/0000950170-25-046656.md) | [(19.1%)](/filings/0000019871-26-000004.md) | [(4.3%)](/filings/0000019871-26-000004.md) | | Net margin | % | [3.3%](/filings/0001193125-23-083675.md) | [8.5%](/filings/0001193125-24-080560.md) | [(14.0%)](/filings/0000950170-25-046656.md) | [(20.8%)](/filings/0000019871-26-000004.md) | [(3.9%)](/filings/0000019871-26-000004.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(1.7)](/filings/0001193125-23-083675.md) | [(2.2)](/filings/0001193125-24-080560.md) | [(3.0)](/filings/0000950170-25-046656.md) | [(0.8)](/filings/0000019871-26-000004.md) | [(1.6)](/filings/0000019871-26-000004.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cvr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $559.3k | 53,757 | | Reduced −2,006 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $284.2k | 27,310 | | Reduced −1,100 | | [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $262.2k | 25,200 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $102.4k | 9,844 | | Added +2,154 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $87.2k | 8,384 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $39.7k | 3,819 | | Unchanged | | [HARBOUR INVESTMENTS, INC.](/funds/810121.md) | 2026-06-30 | $14.7k | 1,409 | | Added +1 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $10 | 1 | | Unchanged | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $8 | 1 | | Unchanged | ## Recent filings [All 225 filings](/companies/cvr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 17:07 ET | [10-Q](/filings/0000019871-26-000022.md) | Quarterly report, period 2026-06-30 | 0000019871-26-000022 | | 2026-05-14 | 17:04 ET | [8-K](/filings/0000019871-26-000019.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000019871-26-000019 | | 2026-05-08 | 16:38 ET | [10-Q](/filings/0000019871-26-000014.md) | Quarterly report, period 2026-03-31 | 0000019871-26-000014 | | 2026-04-03 | 19:35 ET | [DEF 14A](/filings/0000019871-26-000010.md) | Proxy statement, period 2026-04-02 | 0000019871-26-000010 | | 2026-03-24 | 15:31 ET | [10-K](/filings/0000019871-26-000004.md) | Annual report, period 2025-12-31 | 0000019871-26-000004 | | 2025-12-29 | 09:10 ET | [SCHEDULE 13D](/filings/0001731122-25-001730.md) | Ownership report, active investor | 0001731122-25-001730 | | 2025-12-12 | 18:15 ET | [SCHEDULE 13D](/filings/0002056058-25-000003.md) | Ownership report, active investor | 0002056058-25-000003 | | 2025-11-07 | 14:12 ET | [10-Q](/filings/0000019871-25-000008.md) | Quarterly report, period 2025-09-30 | 0000019871-25-000008 | | 2025-08-08 | 14:21 ET | [10-Q](/filings/0000950170-25-105683.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105683 | | 2025-06-10 | 14:16 ET | [8-K/A](/filings/0000950170-25-084242.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-084242 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000019871-26-000004.md), filed Mar 24, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bb309121-8038-4adc-903d-4e04f96c749a) ## About the filer - CIK: 19871 - Tickers: CVR - Exchange: NYSE - SIC code: 3540 Metalworkg Machinery & Equipment - State of incorporation: IL - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.